R&G PharmaStudies is Pharmaceuticals in China that focus on data management business. Founded in 2008. They cover business area such as Provider, research service, pharmaceutical industry, contractual statistical consulting, regulatory, clinical trial design, supervise, protocol design, statistical analysis, SAS programming and data management obligation, pharmaceutical company, Phase, I.
2008
( 16 years old in 2024 )
Data Management
-
North Tower, Building B, Floor 11
19 West Chegongzhuang Road Huatong Plaza, Haidian District
Beijing
China
Private
Providerresearch servicepharmaceutical industrycontractual statistical consultingregulatory, clinical trial designsuperviseprotocol designstatistical analysisSAS programming and data management obligationpharmaceutical companyPhaseI
* We use standard office opening hours in near R&G PharmaStudies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
R&G PharmaStudies is Pharmaceuticals business from China that founded in 2008 (16 years old in 2024), R&G PharmaStudies business is focusing on Data Management.
R&G PharmaStudies headquarter office and corporate office address is located in North Tower, Building B, Floor 11 19 West Chegongzhuang Road Huatong Plaza, Haidian District Beijing China.
R&G PharmaStudies was founded in China.
In 2024, R&G PharmaStudies is currently focus on data management sector.
Above is snippet of Google Trends for "data management" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with R&G PharmaStudies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
